Performing Country-led Economic Evaluations to Inform Immunization Policy: ProVac Experiences in Latin America and the Caribbean

Value in Health Regional Issues

Volumn 1, Issue 2, 2012, Pages 248-253

  Janusz, Cara B ^a   Jauregui, Barbara ^a   Sinha, Anushua ^b   Clark, Andrew D ^c   Bolaños, Brenda M ^c   Resch, Stephen ^d   Toscano, Cristiana ^e   Andrus, Jon K ^a  

^a PAN AMERICAN HEALTH ORGANIZATION   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Cost effectiveness analysis; Economic evaluations; Evidence based policy; National immunization programs

Indexed keywords

10 VALENT PNEUMOCOCCAL CONJUGATE VACCINE; 13 VALENT PNEUMOCOCCAL CONJUGATE VACCINE; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ARTICLE; CASE STUDY; CENTRAL AMERICA; COST EFFECTIVENESS ANALYSIS; DRUG COST; ECONOMIC EVALUATION; EVIDENCE BASED PRACTICE; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; IMMUNIZATION; MEDICAL DECISION MAKING; NICARAGUA; PARAGUAY; PRIORITY JOURNAL; SOUTH AND CENTRAL AMERICA;

EID: 84870931890     PISSN: 22121099     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vhri.2012.10.003     Document Type: Article

References (10)

1. Andrus J.K., Jauregui B., Oliveira L., Ruíz Matus C. Challenges to building capacity for evidence-based new vaccine policy in developing countries. Health Aff (Millwood) 2011, 30:1104-1112.
2. Andrus J.K., Dietz V., Fitzsimmons J., Castillo-Solórzano C. Accelerating policy, deployment and access to new and underutilized vaccines in developing countries. Harvard Health Policy Rev 2006, 7:91-101.
3. Andrus J.K., Toscano C.M., Lewis M., et al. A model for enhancing evidence-based capacity to make informed policy decisions on the introduction of new vaccines in the Americas: PAHO's ProVac Initiative. Public Health Rep 2007, 122:812-816.
4. Burns J.E., Mitrovich R.C., Jauregui B., et al. Descriptive analysis of immunization policy decision making in the Americas. Rev Panam Salud Publica 2009, 26:398-404.
5. Wolfson L.J., Gasse F., Lee-Martin S.P., et al. Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2016. Bull World Health Org 2008, 86:27-39.
6. Jauregui B., Sinha A., Clark A., et al. Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: lessons learned by PAHO's ProVac Initiative. Vaccine 2011, 29:1099-1106.
7. Black RE, Cousens S, Johnson H., et al. Global, regional and national causes of child mortality in 2008: a systematic analysis. Lancet 2012;375:1969-1987.
8. Clark A, Jauregui B, Griffiths C, Janusz C, Bolaños-Sierra B et al. TRIVAC decision-support model for evaluating the costeffectiveness of haemophilus influenzae type b, pneumococcal and rotavirus vaccination in low-income and middle-income countries. Vaccine 2013. In press.
9. Valenzuela M.T., O'Loughlin R., De La Hoz F., et al. The burden of pneumococcal disease among Latin American and Caribbean children: a review of the evidence. Pan Am J Public Health 2009, 25:270-279.
10. World Health Organization. WHO Guide for Standardization of Economic Evaluations of Immunization Programmes. Geneva: WHO Press, 2008.